(4S)-PROTAC SOS1 degrader-1 (diTFA)
CAT:
804-HY-144657A-05
Size:
100 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

(4S)-PROTAC SOS1 degrader-1 (diTFA)
- UNSPSC Description: (4S)-PROTAC SOS1 degrader-1 (diTFA) is a potent PROTAC SOS1 degrader. (4S)-PROTAC SOS1 degrader-1 (diTFA) decreases the expression of pERK and RAS-GTP level in a dose-dependent manner. (4S)-PROTAC SOS1 degrader-1 (diTFA) significantly inhibits the tumor growth in vivo[1].
- Target Antigen: PROTACs; Ras
- Type: Reference compound
- Related Pathways: GPCR/G Protein;MAPK/ERK Pathway;PROTAC
- Applications: Cancer-Kinase/protease
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/4s-protac-sos1-degrader-1-ditfa.html
- Solubility: DMSO : 100 mg/mL (ultrasonic)
- Smiles: O=C(N[C@@H](C(C)(C)C)C(N1C[C@@H](O)C[C@H]1C(N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)=O)=O)CCCCCCCCN4CCN(CC4)C5=C6N=C(N7CC8(CNC8)C7)N(CC9=CC(C)=C(F)C(C)=C9)C6=CC(Cl)=C5.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
- Molecular Weight: 1279.84
- References & Citations: [1]Zhou C,et al. Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations. J Med Chem. 2022; 65(5):3923-3942.
- Shipping Conditions: Blue Ice
- Clinical Information: No Development Reported